SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-22-009983
Filing Date
2022-03-17
Accepted
2022-03-17 21:00:32
Documents
1
Period of Report
2022-03-11

Document Format Files

Seq Description Document Type Size
1 FORM 4/A form4.html 4/A  
1 FORM 4/A form4.xml 4/A 3898
  Complete submission text file 0001140361-22-009983.txt   5586
Mailing Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220
Business Address 140 58TH STREET, BUILDING A SUITE 2100 BROOKLYN NY 11220 (212) 582-1199
Brooklyn ImmunoTherapeutics, Inc. (Issuer) CIK: 0000748592 (see all company filings)

IRS No.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2231 RUTHERFORD ROAD SUITE 200 CARLSBAD CA 92008
Business Address
Gurrola Sandra M (Reporting) CIK: 0001618457 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-11460 | Film No.: 22750823